Sulfated Hydrogel for HSV-1 Binding via Dendritic Polyglycerol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antiviral materials for HSV-1 are not highly biocompatible and are difficult to manufacture, and there is a need for a material that can effectively bind viruses and be used in various medical applications.
Innovation Solution
A sulfated hydrogel comprising dendritic polyglycerol units and polyether units, covalently bound through specific chemical bonds, is developed using a click conjugation approach with PEG dithiol and dendritic polyglycerol sulfate maleimide, creating a hydrogel with controlled flexibility and high negative charge for multivalent virus binding.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sulfated dendritic polyglycerol nanogels are used as antiviral agents, then virus binding efficacy is improved, but manufacturing complexity increases
Solution Approach 1:
The invention divides the complex sulfated dendritic polyglycerol structure into two separate components: a hydrogel matrix and sulfated dendritic polyglycerol units. These components are synthesized independently and then combined through physical entanglement and electrostatic interactions, simplifying the manufacturing process while maintaining high virus binding efficacy through the preserved multivalent sulfate groups.
Solution Approach 2:
The invention creates a composite hydrogel system combining poly(ethylene glycol) diacrylate matrix with sulfated dendritic polyglycerol units. This composite approach allows each component to contribute its specific properties: the PEG diacrylate provides structural framework and biocompatibility, while the sulfated dPG units provide high-affinity virus binding through multivalent electrostatic interactions, achieving enhanced efficacy without proportionally increasing manufacturing complexity.
2Reliability
If flexible nanogel structures are used to inhibit virus, then antiviral efficacy is improved, but structural stability deteriorates
Solution Approach 1:
The invention applies different mechanical properties to different parts of the system: the hydrogel matrix provides structural stability and rigidity, while the sulfated dendritic polyglycerol units maintain local flexibility to enable conformational adjustments during virus binding. This local differentiation allows the flexible units to achieve high antiviral efficacy while the overall structure remains stable.
Solution Approach 2:
The composite structure combines rigid PEG diacrylate crosslinked network with flexible sulfated dendritic polyglycerol units. The rigid matrix provides structural integrity and stability, while the flexible sulfated units can dynamically interact with viruses through electrostatic interactions, achieving both structural stability and high antiviral efficacy simultaneously.
3Reliability
If highly sulfated architectures are used to prevent HSV entry, then antiviral efficacy is improved, but biocompatibility deteriorates
Solution Approach 1:
The invention concentrates the highly sulfated dendritic polyglycerol units at the binding sites within the hydrogel matrix, while the bulk PEG diacrylate matrix maintains neutral biocompatibility. This local concentration allows high antiviral efficacy at the virus interaction interface while the overall material maintains good biocompatibility through the biologically inert PEG matrix.
Solution Approach 2:
The PEG diacrylate hydrogel matrix acts as an intermediary carrier that delivers the highly sulfated dendritic polyglycerol units to the virus binding sites. The PEG matrix provides a biocompatible delivery platform that reduces the direct exposure of highly sulfated structures to biological tissues, thereby maintaining biocompatibility while preserving antiviral efficacy through the sulfated units.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel demonstrates enhanced virus binding efficacy, particularly for HSV-1, with flexible sulfated hydrogels showing up to 30 times higher binding capacity than non-sulfated counterparts, and exhibits antiviral properties suitable for various medical uses including antiviral therapy and mucus replacement.
Implementation Method 1
HSV-1 uses its surface glycoprotein to bind to heparan sulfate proteoglycans (HSPG) to start the infection in host cells. Because the virus entry is primarily driven by electrostatic interactions, many drug designs have been inspired by the sulfate-dominant interactions.
Implementation Method 2
Dey et. al. fabricated sulfated dendritic polyglycerol (dPGS) nanogels as synthetic heparan sulfate mimics of a range of flexibilities as well as sizes. While all the nanogels were successful in inhibiting virus, the more flexible nanogels showed higher efficacy.
Data Source
AI summary
It is provided a hydrogel comprising dendritic polyglycerol units and polyether units. The dendritic polyglycerol units correspond to general formula (I). They comprise a dendritic polyglycerol core having terminal hydroxyl groups and terminal sulfate or sulfonate substituents, wherein a degree of substitution of the dendritic polyglycerol core with sulfate or sulfonate substituents lies in a range from 10% to 98%. The polyether units correspond to general formula (II), wherein the dendritic polyglycerol units and the polyether units are covalently bound to each other via the bonds illustrated by dashed lines in formula (I) and formula (II). The hydrogel has antiviral properties and can be used, e.g., as mucus replacement, cartilage replacement, or synovial fluid replacement.